Pulsatile delivery of amoxicillin against Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1067-1071

  Cha, Raymond ^a,b   Rybak, Michael J ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Controlled drug release; In vitro models; Intermediate resistance; Pharmacodynamics

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; CONTROLLED STUDY; DENSITY; DRUG EXPOSURE; DRUG INTERMITTENT THERAPY; DRUG PULSE THERAPY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; QUANTITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; COMPUTER SIMULATION; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; STREPTOCOCCUS PNEUMONIAE;

EID: 12344315926     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh452     Document Type: Article

References (11)

1. Bartlett, J. G., Breiman, R. F., Mandell, L. A. et al. (1998). Community-acquired pneumonia in adults: guidelines for management. Clinical Infectious Diseases 26, 811-38.
2. Chambers, H. F. (2000). Penicillins. In Principles and Practice of Infectious Diseases, 5th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 261-74. Churchill Livingstone, Philadelphia, PA, USA.
3. Preston, S. L. & Drusano, G. L. (1999). Penicillins. In Antimicrobial Therapy and Vaccines (Yu, V. L, Merigan, T. C., Jr & Barriere, S. L., Eds), pp. 850-75. Williams & Wilkins, Baltimore, MD, USA.
4. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
5. Rowan, N. J., MacGregor, S. J., Anderson, J. G. et al. (1999). Pulsed-light inactivation of food-related microorganisms. Applied and Environmental Microbiology 65, 1312-5.
6. Cappelletty, D. M. & Rybak, M. J. (1996). Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model. Antimicrobial Agents and Chemotherapy 40, 1148-52.
7. Campbell, G. D., Jr & Silberman, R. (1998). Drug-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 26, 1188-95.
8. Centers for Disease Control and Prevention. (1999). Defining the public health impact of drug-resistant Streptococcus pneumoniae report of a working group. Morbidity and Mortality Weekly Report: Recommendations and Reports 45, RR-1, 1-20.
9. Friedland, I. R. & McCracken, G. H., Jr (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
10. Tomasz, A. (1979). From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view. Review of Infectious Diseases 1, 434-67.
11. Drusano, G. L. & Craig, W. A. (1997). Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Journal of Chemotherapy 9, Suppl. 3, 38-44.